2023

  1. ICD-10-CM Codes
    2. ›
  2. C00-D49
    3. ›
  3. D00-D09
    4. ›
  4. D06-
    5. ›
  5. 2023 ICD-10-CM Diagnosis Code D06.1

2023 ICD-10-CM Diagnosis Code D06.1

Carcinoma in situ of exocervix

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Female Dx
  • D06.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM D06.1 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of D06.1 - other international versions of ICD-10 D06.1 may differ.
ICD-10-CM Coding Rules
  • D06.1 is applicable to female patients.
The following code(s) above D06.1 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D06.1:
  • C00-D49
    2023 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D00-D09
    2023 ICD-10-CM Range D00-D09

    In situ neoplasms

    Includes
    • Bowen's disease
    • erythroplasia
    • grade III intraepithelial neoplasia
    • Queyrat's erythroplasia
    In situ neoplasms
  • D06
    ICD-10-CM Diagnosis Code D06

    Carcinoma in situ of cervix uteri

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Includes
    • cervical adenocarcinoma in situ
    • cervical intraepithelial glandular neoplasia
    • cervical intraepithelial neoplasia III [CIN III]
    • severe dysplasia of cervix uteri
    Type 1 Excludes
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cytologic evidence of malignancy of cervix without histologic confirmation (R87.614)
    • high grade squamous intraepithelial lesion (HGSIL) of cervix (R87.613)
    • melanoma in situ of cervix (D03.5)
    • moderate cervical dysplasia (N87.1)
    Carcinoma in situ of cervix uteri
Approximate Synonyms
  • Carcinoma in situ, exocervix
ICD-10-CM D06.1 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 736 Uterine and adnexa procedures for ovarian or adnexal malignancy with mcc
  • 737 Uterine and adnexa procedures for ovarian or adnexal malignancy with cc
  • 738 Uterine and adnexa procedures for ovarian or adnexal malignancy without cc/mcc
  • 739 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with mcc
  • 740 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with cc
  • 741 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy without cc/mcc
  • 754 Malignancy, female reproductive system with mcc
  • 755 Malignancy, female reproductive system with cc
  • 756 Malignancy, female reproductive system without cc/mcc

Convert D06.1 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change

Diagnosis Index entries containing back-references to D06.1:

ICD-10-CM Codes Adjacent To D06.1
D05.8 Other specified type of carcinoma in situ of breast
D05.80 Other specified type of carcinoma in situ of unspecified breast
D05.81 Other specified type of carcinoma in situ of right breast
D05.82 Other specified type of carcinoma in situ of left breast
D05.9 Unspecified type of carcinoma in situ of breast
D05.90 Unspecified type of carcinoma in situ of unspecified breast
D05.91 Unspecified type of carcinoma in situ of right breast
D05.92 Unspecified type of carcinoma in situ of left breast
D06 Carcinoma in situ of cervix uteri
D06.0 Carcinoma in situ of endocervix
D06.1 Carcinoma in situ of exocervix
D06.7 Carcinoma in situ of other parts of cervix
D06.9 Carcinoma in situ of cervix, unspecified
D07 Carcinoma in situ of other and unspecified genital organs
D07.0 Carcinoma in situ of endometrium
D07.1 Carcinoma in situ of vulva
D07.2 Carcinoma in situ of vagina
D07.3 Carcinoma in situ of other and unspecified female genital organs
D07.30 Carcinoma in situ of unspecified female genital organs
D07.39 Carcinoma in situ of other female genital organs
D07.4 Carcinoma in situ of penis

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Advertise with Us | License ICD10 Data

Copyright © | ICD10data.com